Transglutaminase activity in acute infarcts predicts healing outcome and left ventricular remodelling: implications for FXIII therapy and antithrombin use in myocardial infarction-Reference-Cited by-同舟云学术

Transglutaminase activity in acute infarcts predicts healing outcome and left ventricular remodelling: implications for FXIII therapy and antithrombin use in myocardial infarction

Published:2008-02 Issue:4 Volume:29 Page:445-454
ISSN:1522-9645
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Nahrendorf Matthias,Aikawa Elena,Figueiredo Jose-Luiz,Stangenberg Lars,van den Borne Susanne W.,Blankesteijn W. Matthijs,Sosnovik David E.,Jaffer Farouc A.,Tung Ching-Hsuan,Weissleder Ralph

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/29/4/445/17048441/ehm558.pdf

Reference34 articles.

1. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both;Pfeffer;N Engl J Med,2003

2. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications;Pfeffer;Circulation,1990

3. Cellular basis of ventricular remodeling after myocardial infarction;Anversa;Am J Cardiol,1991

4. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy;Sutton;Circulation,2000

5. Serial cine-magnetic resonance imaging of left ventricular remodeling after myocardial infarction in rats;Nahrendorf;J Magn Reson Imaging,2001

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of macrophages and their exosomes in ischemic heart disease;Frontiers in Immunology;2024-05-10

2. Differential Role of Factor XIII in Acute Myocardial Infarction and Ischemic Stroke;Biomedicines;2024-02-22

3. Genetic landscape in coagulation factor XIII associated defects – Advances in coagulation and beyond;Blood Reviews;2023-05

4. Implications of enigmatic transglutaminase 2 (TG2) in cardiac diseases and therapeutic developments;Biochemical Pharmacology;2022-07

5. Bioinformatics and Experimental Analyses Reveal NFIC as an Upstream Transcriptional Regulator for Ischemic Cardiomyopathy;Genes;2022-06-13